While semaglutide primarily acts on the GLP-1 receptor, retatrutide's triple-agonist approach provides a more comprehensive mechanism, which may provide faster and greater weight loss
Adapted from KDIGO 2022 [81]
Generic drugmakers may file ANDA (Abbreviated New Drug Application) lawsuits under the Hatch-Waxman Act, claiming that some of Novo Nordisks patents are invalid or not infringed
Sync your verification via a Webhook, and we'll show a custom message to the Applicant
However, immune neutralization of GIP or removal of GIP from intestinal extracts does not completely eliminate the insulin-stimulating activity, indicating that there are other substances with insulin-stimulating activity in the intestine (Drucker, 1998)
If they are unable to resolve the outstanding demands during the Mediation Period, and cannot agree on a methodology for resolving them through further arbitrations, either Agile or any remaining claimant may opt out of the arbitration process and have the demand(s) proceed in court